Skip to main content

Phototherapy Devices Market Size Worth USD 949.89 Million in 2032 | Emergen Research

Increasing R & D for the development of technologically advanced devices and growing incidences of skin diseases and neonatal jaundice are driving the demand of the Phototherapy Devices Market

Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global Phototherapy Devices Market is expected to reach USD 949.89 Million by 2032, according to a new report by Emergen Research. The growth of this market can be attributed to the growing awareness among patients about the advanced diagnostic solutions provided by the improved healthcare structure. Increasing research and development by the key manufacturers for the technological advancement of the devices is augmenting the demand for the industry.

 The pandemic has caused a shortage of essential life-saving devices and medical supplies. It has severely disrupted the supply chain and raw material supplies. To meet the growing demand of the medical supplies in between the pandemic, manufacturers have increased their production capacity. The manufacturers are adopting safety regulations and preventive measures without hampering the manufacturing process.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/120

Scope of Research

Report DetailsOutcome
Market size value in 2019USD 530.3 Million
CAGR (2023 – 2032)4.6%
Revenue forecast in 2032USD 949.89 Million
Base year for estimation2022
Historical data2019-2021
Forecast period2023-2032
Quantitative unitsVolume in Tons, Revenue in USD Thousand, and CAGR from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct, Application, End User, region
Regional scopeNorth America; Europe; Asia Pacific; Central & South America; MEA
Country scopeU.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiledNatus Medical Incorporated, Philips Lighting Holding B.V., GE Healthcare, Atom Medical Corporation, Herbert Waldmann GmbH & Co. KG, Phoenix Medical Systems Pvt. Ltd., Nice Neotech Medical Systems Pvt. Ltd., Solarc Systems Inc., National Biological Corporation, and The Daavlin Company
Customization scope10 hrs of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @
https://www.emergenresearch.com/request-discount/120

MAJOR COMPANIES and Market Share Analysis

The Phototherapy Devices Market is moderately fragmented with a large number of small and medium-sized manufacturers, which account for a major part of the global share. The manufacturers are well-equipped with manufacturing facilities and are involved in several research & development activities. Some of the prominent players in the Phototherapy Devices Market include:

  • Natus Medical Incorporated
  • Philips Lighting Holding B.V.
  • GE Healthcare
  • Atom Medical Corporation
  • Herbert Waldmann GmbH & Co. KG
  • Phoenix Medical Systems, Pvt. Ltd.
  • Nice Neotech Medical Systems Pvt. Ltd.
  • Solarc Systems Inc.
  • National Biological Corporation
  • The Daavlin Company

Strategic Development

In March 2017, Monica Healthcare was acquired by GE Healthcare. The acquisition was performed by GE Healthcare to expand its business of maternal-infant care and to remain competitive in the growing industry.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @
https://www.emergenresearch.com/select-license/120

Key Highlights From The Report

  • LED-Based Phototherapy Devices dominate the market with a share of 55.8% in 2019 due to its cost-effectiveness and higher efficiency. 
  • The Hospitals & clinics segment dominated the phototherapy devices market due to the increasing number of neonatal jaundice cases. Besides, the favorable reimbursement policies generated by the U.S. government for curing skin conditions will indeed shift the patient’s preference towards hospital treatments. 
  • Asia-Pacific is expected to be the fastest-growing segment over the forecast period due to the enhancement of the healthcare infrastructure with advanced diagnostic solutions.   

Browse Full Report Description + Research Methodology + Table of Content + Infographics@
https://www.emergenresearch.com/industry-report/phototherapy-devices-market

Emergen Research has segmented the global Phototherapy Devices Market on the basis of Product, Application, End User, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2032)
    • LED-Based Phototherapy  Devices
    • Fibreoptic Phototherapy  Devices
    • Conventional Phototherapy Devices (Fluorescent Lamps, Compact Fluorescent Lamps)
  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Neonatal Jaundice Management
    • Skin Disease Treatment (Vitiligo, Eczema, Psoriasis)
  • End User Outlook (Revenue, USD Billion; 2019-2032)
    • Homecare
    • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Human Microbiome Modulators Market By Product (Probiotics and Creams, Prebiotics and Dietary Supplements and Drugs), By Application (Digestive Health, Immune Health, Women’s Health, Oral Health, and Others), and By Region Forecast to 2030

Nanopharmaceutical Drugs Market By Type (Therapeutics, Regenerative Medicine, and Diagnostics), By Application (Clinical Oncology, Infectious Diseases, and Cardiovascular Diseases), By Nanomolecule, and By Region Forecast To 2030

Nerve Repair and Regeneration Market, By Product (Biomaterials and Neuromodulator devices), By Applications (Stem cell therapy and nerve grafting) By End-Use (Hospitals and clinics and Ambulatory services), and By Region Forecast to 2030

Immunotherapy Drugs Market By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines, and Others), By Disease (Cancer, Autoimmune Diseases, Infectious Diseases, and Others), and By Region Forecast To 2030

Healthcare Supply Chain Management Market By Component (Software, Hardware), By Delivery Mode (On-premises Delivery, Cloud-based Delivery), By End-user (Manufacturers, Providers, Distributors), and By Region Forecast to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Phototherapy Devices Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-phototherapy-devices-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.